We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Ovarian Cancer Screening Not Recommended by New Guidelines

By HospiMedica International staff writers
Posted on 28 Feb 2018
Print article
New guidelines released by the U.S. Preventive Services Task Force (USPSTF; Rockville, MD, USA) recommend against screening for ovarian cancer in women without symptoms.

The recommendation statement followed a review of evidence on the benefits and harms of screening in asymptomatic women not known to be at high risk for ovarian cancer. Given the lack of mortality benefit of screening, and the moderate to substantial harms that could result from false-positive screening test results and subsequent surgery, the USPSTF concluded with moderate certainty that the harms of screening for ovarian cancer outweigh the benefit, and the net balance of the benefit and harms of screening is negative.

The USPSTF further discourages all methods for routine screening, including transvaginal ultrasound, serum CA-125 testing, and pelvic examination with bimanual palpation of the ovaries, based on the results of three large good-quality studies. Adequate evidence from the same studies shows that the harms from screening for ovarian cancer, such as false-positive results, may lead to unnecessary diagnostic surgery to determine whether ovarian cancer is present, often resulting in removal of one or both of the ovaries and fallopian tubes, and that serious surgical complications can also result.

The recommendation applies to asymptomatic women who are not known to have a high-risk hereditary cancer syndrome. Women with certain hereditary cancer syndromes, such as BRCA1 or BRCA2 genetic mutations associated with hereditary breast and ovarian cancer syndrome, as well as women with a family history of ovarian or breast cancer should consult with a health care professional. The USPSTF added that management of a diagnosed hereditary cancer syndrome and prevention of ovarian cancer in such women is beyond the scope of the recommendation statement.

“Ovarian cancer is a devastating disease, and we do not have a good way to identify women with ovarian cancer early enough to treat it effectively,” said USPSTF member Chien-Wen Tseng, MD, MPH, of the University of Hawaii (Honolulu, USA). “The task force is calling for research to find better screening tests and treatments that can help reduce the number of women who die from ovarian cancer.”

Ovarian cancer is the fifth most common cause of cancer death among U.S. women, with approximately 14,000 deaths per year. Symptoms are usually nonspecific and can include abdominal pain or pressure, bloating, constipation, urinary symptoms, back pain, or fatigue. Most women with ovarian cancer are diagnosed at later stages, and approximately 60% have metastases at the time of diagnosis. Mortality rates vary by stage at diagnosis; 5-year survival rates range from 92.5% for localized cancer to 28.9% for cancer with distant spread.

Related Links:
U.S. Preventive Services Task Force
University of Hawaii

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Hemodynamic Monitoring Sensor
FloTrac Jr

Print article

Channels

Critical Care

view channel
Image: Researchers have developed a novel risk score for cardiovascular complications after bone marrow transplant (Photo courtesy of 123RF)

Novel Tool Predicts Cardiovascular Risks after Bone Marrow Transplantation

Every year, thousands of people undergo bone marrow transplants to potentially cure serious diseases like leukemia, lymphoma, and immune deficiency disorders. While these transplants can be lifesaving,... Read more

Surgical Techniques

view channel
Image: The Early Bird Bleed Monitoring System provides visual and audible indicators of the onset and progression of bleeding events (Photo courtesy of Saranas)

Novel Technology Monitors and Lowers Bleeding Complications in Patients Undergoing Heart Procedures

Bleeding complications at the femoral access site can significantly hamper recovery, affecting the success of procedures, patient satisfaction, and overall healthcare costs. It is crucial for surgeons... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.